Contact

Are you a health worker?

Contact

Are you a health worker?

New heart product – Atenolol Jadran

1 min of reading Published: 26.6.2009.

We added a new product to our line of cardiovascular drugs, a selective β-blocker ATENOLOL JADRAN.
Atenonolol’s long-term administration in clinical practice for the treatment of hypertension, angina, heart arrhythmia and myocardial infarction has made it a synonym for the entire β-blocker group.

Atenolol Jadran is on the CIHI primary list of drugs.

ATENOLOL JADRAN
(atenolol)
tablets 30 x 50 mg
20 x 100 mg

This page uses cookies to ensure a better user experience and site functionality. By continuing to view this website you agree to the use of cookies.

You can read more about privacy and personal data here